Yale Cancer Center

Smilow Cancer Hospital at Yale-New Haven

New Haven, CT

Accepting patients

EXCALIBER RRMM

Phase 3 Clinical Trial Comparing the Safety and Effectiveness of Iberdomide, Daratumumab and Dexamethasone VS Daratumumab, Bortezomib, and Dexamethasone in Patients with Relapsed or Refractory Multiple Myeloma
Learn more
  • CELMoD
  • Randomization
  • Phase 3
All clinical trials have eligibility criteria - or a list of reasons why you may be able or unable to participate in a trial. Answer a few questions to view your personalized results - all in under 60 seconds.
Help me find trials
2 hidden based on your filters. Show All

Filters

Diagnosis

Treatment History

Prior BCMA Therapy

Advanced Filters

Classifications

Trial Enrollment Status